CAPN3 gene analysis

What is calpainopathy?

Calpainopathy, also known as limb-girdle muscular dystrophy type 2A (LGMD2A), is a genetic disorder characterized by muscle weakness and wasting, particularly in the shoulders, hips, and limbs.

What causes calpainopathy?

Calpainopathy is caused by mutations of the calpain 3 (CAPN3) gene. This disease is inherited in an autosomal recessive pattern, which means both copies of the gene (one from each parent) are mutated for an individual to show signs and symptoms of the condition.

What is this test for?

This test detects mutations in all protein-coding regions of the CAPN3 gene and partial flanking non-coding DNA sequences.

Who should consider this test?

Individuals affected with LGMD with family history of calpainopathy or as suggested by clinical findings.

Test Specifications

Test Code
Methodology
Specimen Requirements
Turnaround Time
GCP
Sanger sequencing
6 mL blood in EDTA tube
30 days

Rejection criteria

  • Specimen without proper labeling
  • Specimen not in requested format or insufficient quantity
  • Specimen in container expired for more than 1 month
  • Container leakage
  • Sampling date is more than 7 days
  • Frozen specimen, haemolysed or clotted blood specimen

Factor(s) known to affect results

  • Improper collection, handling and storage of specimen

How to get started

Our tests must be ordered by a doctor. Ask your doctor if a Mygenia test is right for you. We can help you find a doctor if you don’t have one.

I have a doctor